Therapeutic efficacy of the autologous conditioned plasma (ACP™): Cellular composition analysis and literature review;Efficacité thérapeutique de l'autologous conditioned plasma (ACP™): Analyse de sa composition cellulaire et revue de la littérature

Journal de Traumatologie du Sport

Volumn 30, Issue 4, 2013, Pages 211-215

  Bohu, Y ^a,b,c   Klouche, S ^a,b,c   Lefevre, N ^b,c   Herman, S ^b,c   Hardy, P ^a,d  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Institut de l'appareil locomoteur Nollet   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Autologous conditioned plasma (ACP ); Platelet count; Review of the literature; Therapeutic efficacy

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS CONDITIONED PLASMA; BLOOD; BLOOD CELL COUNT; BLOOD SAMPLING; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; HUMAN; INJECTION; MALE; TENDINITIS; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; VENOUS BLOOD;

EID: 84889569301     PISSN: 0762915X     EISSN: 17730465     Source Type: Journal    
DOI: 10.1016/j.jts.2013.07.002     Document Type: Article

References (21)

1. de Mos M., van der Windt A.E., Jahr H., van Schie H.T., Weinans H., Verhaar J.A., et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 2008, 36:1171-1178.
2. Marx R.E. Platelet-Rich Plasma (PRP): what is PRP and what is not PRP?. Implant Dent 2001, 10:225-228.
3. Sundman E.A., Cole B.J., Fortier L.A. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 2011, 39:2135-2140.
4. Mazzocca A.D., McCarthy M.B., Chowaniec D.M., Cote M.P., Romeo A.A., Bradley J.P., et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 2012, 94:308-316.
5. Sainssou B., Kelberine F., Malgoyres A., Alonso A., Bigard X. Platelet-rich plasma: what do we inject?. World Sports Trauma Congress 2012, 17-20. [OP0208].
6. Kaux J.F., Le Goff C., Seidel L., Péters C., Gothot A., Albert A., et al. Comparative study of five technics of preparation of platelet-rich plasma. Pathol Biol (Paris) 2011, 59:157-160.
7. Ferrand M., Levy B., Klouche S., Bauer T., Hardy P. Comparative prospective study of arthroscopic repair of transfixing ruptures of rotator cuff with or without injection of autologous conditioned plasma. SECEC 2012, 19-22. [OP7].
8. Georg R., Maria C., Gisela A., Bianca C. Autologous conditioned plasma as therapy of tendon and ligament lesions in seven horses. J Vet Sci 2010, 11:173-175.
9. Stief M., Gottschalk J., Ionita J.C., Einspanier A., Oechtering G., Böttcher P. Concentration of platelets and growth factors in canine autologous conditioned plasma. Vet Comp Orthop Traumatol 2011, 24:122-125.
10. Milano G., Deriu L., Sanna Passino E., Masala G., Manunta A., Postacchini R., et al. Repeated platelet concentrate injections enhance reparative response of microfractures in the treatment of chondral defects of the knee: an experimental study in an animal model. Arthroscopy 2012, 28:688-701.
11. Schippinger G., Fankhauser F., Oettl K., Spirk S., Hofmann P. Does single intramuscular application of autologous conditioned plasma influence systemic circulating growth factors?. J Sports Sci Med 2012, 11:551-556.
12. Deans V.M., Miller A., Ramos J. A prospective series of patients with chronic Achilles tendinopathy treated with autologous-conditioned plasma injections combined with exercise and therapeutic ultrasonography. J Foot Ankle Surg 2012, 51:706-710.
13. Cerza F., Carnì S., Carcangiu A., Di Vavo I., Schiavilla V., Pecora A., et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 2012, 40:2822-2827.
14. Browning S.R., Weiser A.M., Woolf N., Golish S.R., Sangiovanni T.P., Scuderi G.J., et al. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. J Bone Joint Surg Am 2012, 94:e1721-e1727.
15. Chan Y.S., Li Y., Foster W., Fu F.H., Huard J. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 2005, 33:43-51.
16. Faurschou M., Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003, 5:1317-1327.
17. Lenzlinger P.M., Morganti-Kossmann M.C., Laurer H.L., McIntosh T.K. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 2001, 24:169-181.
18. Watelet J.B., Demetter P., Claeys C., Van Cauwenberge P., Cuvelier C., Bachert C. Neutrophil-derived metalloproteinase-9predicts healing quality after sinus surgery. Laryngoscope 2005, 115:56-61.
19. Sheth U., Simunovic N., Klein G., Fu F., Einhorn T.A., Schemitsch E., et al. Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. J Bone Joint Surg Am 2012, 94:298-307.
20. Wasterlain A.S., Braun H.J., Harris A.H., Kim H.J., Dragoo J.L. The systemic effects of platelet-rich plasma injection. Am J Sports Med 2013, 41:186-193.
21. Heisterbach P.E., Todorov A., Flückiger R., Evans C.H., Majewski M. Effect of BMP-12, TGF-β1and autologous conditioned serum on growth factor expression in Achilles tendon healing. Knee Surg Sports Traumatol Arthrosc 2012, 20:1907-1914.